首页 › 基金 › SHAPIRO CAPITAL MANAGEMENT LLC › GENI

SHAPIRO CAPITAL MANAGEMENT LLC 对 GENI 的持仓历史

GENIUS SPORTS LIMITED · 可选消费

SHAPIRO CAPITAL MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 GENI(GENIUS SPORTS LIMITED)9,790,280 股,市值约 US$56.1M,约占其申报组合的 3.84%,在其申报持仓中市值排名第 4 位。 SHAPIRO CAPITAL MANAGEMENT LLC 最近 5 个申报季度中有 5 个季度披露了 GENI 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q3 2026)9.79M 股
申报持仓市值$56.10M
组合权重3.84%
首次申报Q3 2025
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

SHAPIRO CAPITAL MANAGEMENT LLC 对 GENI 的持仓演变

SHAPIRO CAPITAL MANAGEMENT LLC 于 Q3 2025 首次披露 GENI 持仓:1,587,365 股(约 US$19.7M)。 该持仓在 Q2 2026 达到峰值 9,887,255 股,市值约 US$59.9M。 在 5 次申报中,SHAPIRO CAPITAL MANAGEMENT LLC 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 9,790,280 股、市值约 US$56.1M,环比减持 -96,975 股。。 持仓曾出现大幅变动:Q4 2025 增持约 54% (随后一个季度股价下跌 60%)、Q1 2026 增持约 334% (随后一个季度股价上涨 37%)。

逐季持仓明细

季度股数金额变化
Q3 2025 1.59M $19.65M 新进
Q4 2025 2.45M $26.95M 增持
Q1 2026 10.61M $47.01M 增持
Q2 2026 9.89M $59.92M 减持
Q3 2026 9.79M $56.10M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GENI 与 13F 数据

GENI(GENIUS SPORTS LIMITED)属于可选消费行业。我们追踪的基金中还有 21 只申报持有 GENI,申报仓位最大的包括:Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (US$43.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GENI 的基金

查看 GENI 的全部基金持有人 →

常见问题

How long has SHAPIRO CAPITAL MANAGEMENT LLC held GENI?

SHAPIRO CAPITAL MANAGEMENT LLC has disclosed GENI holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is SHAPIRO CAPITAL MANAGEMENT LLC's current position in GENI?

As of Q3 2026, SHAPIRO CAPITAL MANAGEMENT LLC holds 9.79M shares of GENI (GENIUS SPORTS LIMITED), valued at $56.10M, representing 3.84% of its reported portfolio and ranking #4.

Has SHAPIRO CAPITAL MANAGEMENT LLC been buying or selling GENI?

In the latest 13F filing (Q3 2026), SHAPIRO CAPITAL MANAGEMENT LLC reduced its position in GENI. The position peaked in Q2 2026 at 9.89M shares.

Which other funds hold GENI?

Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.